Canopy Growth (CGC) Competitors $1.27 +0.03 (+2.42%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.30 +0.03 (+2.76%) As of 08/22/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CGC vs. ACB, CRON, OGI, SNDL, TLRY, VFF, STZ, WVE, VERA, and ETNBShould you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Constellation Brands (STZ), WAVE Life Sciences (WVE), Vera Therapeutics (VERA), and 89BIO (ETNB). Canopy Growth vs. Its Competitors Aurora Cannabis Cronos Group Organigram Global SNDL Tilray Brands Village Farms International Constellation Brands WAVE Life Sciences Vera Therapeutics 89BIO Aurora Cannabis (NASDAQ:ACB) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk. Do institutionals & insiders hold more shares of ACB or CGC? 47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.2% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts prefer ACB or CGC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00Canopy Growth 2 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.33 Is ACB or CGC more profitable? Aurora Cannabis has a net margin of -5.66% compared to Canopy Growth's net margin of -155.76%. Aurora Cannabis' return on equity of -1.49% beat Canopy Growth's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-5.66% -1.49% -1.06% Canopy Growth -155.76%-89.93%-44.24% Which has stronger earnings & valuation, ACB or CGC? Aurora Cannabis has higher earnings, but lower revenue than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$246.72M1.14$1.63M-$0.19-26.26Canopy Growth$274.92M1.11-$429.86M-$3.03-0.42 Does the media refer more to ACB or CGC? In the previous week, Canopy Growth had 4 more articles in the media than Aurora Cannabis. MarketBeat recorded 5 mentions for Canopy Growth and 1 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 1.00 beat Aurora Cannabis' score of 0.94 indicating that Canopy Growth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Canopy Growth 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, ACB or CGC? Aurora Cannabis has a beta of 1.84, indicating that its stock price is 84% more volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. SummaryAurora Cannabis beats Canopy Growth on 11 of the 16 factors compared between the two stocks. Get Canopy Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGC vs. The Competition Export to ExcelMetricCanopy GrowthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$297.41M$10.84B$5.76B$9.58BDividend YieldN/A1.87%4.41%4.10%P/E Ratio-0.4220.9031.1026.05Price / Sales1.1129.66435.79105.95Price / CashN/A24.5537.7358.48Price / Book0.863.519.536.61Net Income-$429.86M$211.77M$3.26B$265.56M7 Day Performance-2.31%4.44%2.09%1.97%1 Month Performance8.55%8.85%2.81%-0.36%1 Year Performance-79.55%-9.03%30.56%19.03% Canopy Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGCCanopy Growth0.7937 of 5 stars$1.27+2.4%N/A-79.3%$297.41M$274.92M-0.423,150Positive NewsShort Interest ↑ACBAurora Cannabis0.837 of 5 stars$5.21+16.3%N/A-19.1%$294.10M$246.72M-27.421,130High Trading VolumeCRONCronos Group0.7663 of 5 stars$2.67+16.1%N/A+12.6%$1.02B$117.61M53.40450High Trading VolumeOGIOrganigram Global0.4123 of 5 stars$1.64+13.5%N/A-17.5%$219.81M$117.47M16.40860High Trading VolumeSNDLSNDL1.7818 of 5 stars$2.01+19.3%$4.00+99.5%+9.2%$526.87M$944.25M-7.432,516High Trading VolumeTLRYTilray Brands2.6325 of 5 stars$0.92+41.7%$1.92+108.6%-38.5%$1.01B$821.31M-0.402,842High Trading VolumeVFFVillage Farms International1.4623 of 5 stars$2.31+34.3%N/A+181.9%$259.51M$336.18M-6.421,400High Trading VolumeSTZConstellation Brands4.6257 of 5 stars$168.78-1.1%$213.74+26.6%-31.3%$29.75B$10.06B-70.6210,600Positive NewsWVEWAVE Life Sciences4.7948 of 5 stars$8.10+0.1%$20.27+150.2%+83.9%$1.29B$108.30M-9.00240Positive NewsVERAVera Therapeutics3.7665 of 5 stars$20.17+1.9%$63.00+212.3%-42.3%$1.29BN/A-5.6340Positive NewsETNB89BIO2.0524 of 5 stars$8.77-4.4%$26.29+199.7%+11.3%$1.28BN/A-2.4340 Related Companies and Tools Related Companies ACB Competitors CRON Competitors OGI Competitors SNDL Competitors TLRY Competitors VFF Competitors STZ Competitors WVE Competitors VERA Competitors ETNB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CGC) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canopy Growth Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Canopy Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access